| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.27B | 23.83B | 17.46B | 20.78B | 23.60B | 18.52B |
| Gross Profit | 9.98B | 9.35B | 5.19B | 7.34B | 8.93B | 6.41B |
| EBITDA | 6.15B | 5.78B | 1.94B | 4.31B | 5.97B | 3.59B |
| Net Income | 3.57B | 3.45B | 622.00M | 2.61B | 3.80B | 2.04B |
Balance Sheet | ||||||
| Total Assets | 37.80B | 39.86B | 35.08B | 32.96B | 33.21B | 25.77B |
| Cash, Cash Equivalents and Short-Term Investments | 13.71B | 12.19B | 14.25B | 12.81B | 11.87B | 6.81B |
| Total Debt | 5.50B | 5.88B | 5.66B | 4.18B | 5.19B | 6.46B |
| Total Liabilities | 9.75B | 11.94B | 10.41B | 8.72B | 11.42B | 10.36B |
| Stockholders Equity | 28.05B | 27.91B | 24.67B | 24.24B | 21.79B | 15.41B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.66B | 397.00M | 2.43B | 3.89B | 19.00M |
| Operating Cash Flow | 0.00 | 1.80B | 2.31B | 3.35B | 4.81B | 1.42B |
| Investing Cash Flow | 0.00 | -3.58B | -2.20B | -849.00M | -562.00M | -1.50B |
| Financing Cash Flow | 0.00 | -514.00M | 879.00M | -1.58B | 947.00M | 2.97B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥89.22B | 6.87 | ― | 1.72% | 36.31% | 101.77% | |
78 Outperform | ¥221.51B | 14.21 | ― | 3.09% | 14.85% | 29.86% | |
76 Outperform | ¥303.78B | 15.35 | 5.77% | 3.28% | 11.15% | -19.39% | |
71 Outperform | ¥390.25B | 22.63 | ― | 1.02% | 29.60% | 24.39% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
50 Neutral | ¥648.33B | -42.71 | ― | 1.14% | 0.66% | -87.63% |